The Food and Drug Administration (FDA, the Agency, or we) is establishing a public docket to assist with its development of recommendations regarding the communication of risk information in direct-to-consumer (DTC) broadcast advertisements for prescription drugs and biologics.
Document
Content of Risk Information in the Major Statement in Prescription Drug Direct-to-Consumer Broadcast Advertisements; Establishment of a Public Docket; Request for Information and Comments
The Food and Drug Administration (FDA, the Agency, or we) is establishing a public docket to assist with its development of recommendations regarding the communication of risk i...
Legal Citation
Federal Register Citation
Use this for formal legal and research references to the published document.
82 FR 39598
Web Citation
Suggested Web Citation
Use this when citing the archival web version of the document.
“Content of Risk Information in the Major Statement in Prescription Drug Direct-to-Consumer Broadcast Advertisements; Establishment of a Public Docket; Request for Information and Comments,” thefederalregister.org (August 21, 2017), https://thefederalregister.org/documents/2017-17563/content-of-risk-information-in-the-major-statement-in-prescription-drug-direct-to-consumer-broadcast-advertisements-esta.